Translate your idea into product: AI-driven antibody discovery at Evotec
Watch the recorded webinar on AI-driven antibody discovery as part of Evotec’s Innovation Week held in December 2021. A week full of live sessions with…
Learn more
Just – Evotec Biologics’ J.POD® wins CPhI Pharma Award 2022 for Manufacturing Technology and Equipment
Just–Evotec Biologics has been awarded for its flexible cGMP biomanufacturing plant J.POD. The CPhI Award for Manufacturing Technology and Equipment honors innovation in technologies, products,…
Just – Evotec Biologics awarded contract from U.S. Department of Defense under accelerated antibodies program
Just–Evotec Biologics will support the DOD with rapid, cost-efficient development of safe, efficacious anti-plague mabs. Evotec will provide pre-clinical and clinical trial services.
Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)
J.POD® Toulouse, France (EU) Brings a disruptive, flexibly scalable biologics manufacturing technology to the region. The manufacturing facility is expected to be operational in H2…
Just–Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN-303
Just–Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a dual BAFF/APRIL inhibitor for systemic lupus erythematosus…
Evotec receives € 7.5 m grant for development of COVID-19 therapeutic
Under the € 7.5 m grant, Evotec will use clinical material manufactured within its Just – Evotec Biologics manufacturing platform to initiate the clinical development…
Automated multi-attribute method sample preparation using high-throughput buffer exchange tips
In recent years, the multi-attribute method (MAM) has become an important mass spectrometry-based tool for identifying and quantifying the site-specific product attributes and purity information…
Development of recombinase-based targeted integration systems for production of exogenous proteins using transposon-mediated landing pads
Current methods for stably expressing biotherapeutics in CHO cells often rely on random or semi-random integration events which result in widely heterogeneous cell populations. In…
Evotec publishes DDup 11 – AI-driven antibody discovery at Evotec
The 11th edition is dedicated to our exciting new capabilities in the biologics lane of Evotec’s “Multi-modality Autobahn.” For the biologics industry, Evotec provides a…
Introduction to Antibodies
What are antibodies? Antibodies, or immunoglobulin molecules, are glycoproteins produced by the plasma B cells of the adaptive immune system with the aim to recognise…
AI-driven antibody discovery at Evotec
Antibody discovery may be driven by the interrogation of two primary sources: (1) in vivo (animal-derived B cells) or (2) in vitro (library-derived antibody display…
Function-focused antibody (FFmab) screening
What is FFmab screening? FFmab screening is a platform for identifying novel functional antibodies that change disease-modifying phenotypes of immune cells. The platform identifies innovative…